Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | eRAPID: an eHealth intervention during chemotherapy

Galina Velikova • 28 May 2020
ASCO 2020
General
eRAPID

Galina Velikova, BMBS, RCP, PhD, University of Leeds, UK, discusses the phase III eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and advice) study – an eHealth intervention study. eRAPID is an online system for patients to report symptoms during chemotherapy, providing automated severity-dependent advice (self-management or alerts for hospital contact). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology),

More from Galina Velikova

1:17
Late chemotherapy and endocrine therapy toxicities
Galina Velikova • 3 May 2022
1:18
eRAPID: electronic self-reporting of adverse events for patients undergoing cancer treatment
Galina Velikova • 3 May 2022
1:26
eRAPID improves patient self-management of cancer treatment side-effects
Galina Velikova • 3 May 2022
1:09
Sexual dysfunction among breast cancer survivors
Galina Velikova • 3 May 2022

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals